Skip to content

BeiGene

US · ONC #538 by market cap Listed 2016
390.94 -8.76 -2.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q4).
  • Total institutional ownership rose 1.3 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
78.72% +1.28pp
Institutions
636 +1
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund43.98%
Public Company17.52%
Hedge Fund10.11%
VC/PE Fund4.44%
Individual/Insider4.19%
Sovereign Wealth Fund1.11%
Private Company1.05%
Government Pension Fund0.39%
Other17.12%

Top holders as of 2025-12-31

Amgen Inc. 16.58% · 18.94M sh
Capital Research 9.44% · 10.78M sh
Baker Bros. Advisors LP 7.77% · 8.87M sh
PRIMECAP Management Company 4.30% · 4.91M sh
Hillhouse Capital Management, Ltd. 3.71% · 4.24M sh
John Oyler 3.21% · 3.67M sh
BlackRock 2.89% · 3.30M sh
China Asset Management Co., Ltd. 2.63% · 3.00M sh
Vanguard Capital Management, LLC 2.37% · 2.71M sh
FMR 2.01% · 2.29M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 13 buys · 35 sells

NameRoleStake
Amgen Inc. -- 16.58%
John Oyler Chairperson & CEO 3.21%
Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder 0.63%
Wang Lai President and Global Head of Research & Development 0.15%
Xiaobin Wu Former President 0.05%
Felix Baker Independent Non-Executive Director 0.02%
Chan Lee General Counsel, Senior VP & Corporate Secretary 0.02%
Michael Goller Former Independent Non-Executive Director 0.02%
Ranjeev Krishana Former Lead Independent Director 0.02%
Julia A. Wang Former CFO & Principal Financial Officer 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-08 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Other Disposition -1,183 --
2026-11-05 Titus Ball Vice President Derivative Exercise and Sale -1,559 $159.03–406.34
2026-11-04 Chan Lee General Counsel, Senior VP & Corporate Secretary Private Disposition -1,115 $400.00–402.00
2026-10-26 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,028 $36.90–366.22
2026-10-12 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,027 $36.90–353.24
2026-09-29 Chan Lee General Counsel, Senior VP & Corporate Secretary Automatic Disposition -1,115 $375.00
2026-09-27 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,028 $36.90–367.23
2026-09-07 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Automatic Disposition -7,260 $345.38–348.01
2026-09-07 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,027 $36.90–351.25
2026-08-31 Titus Ball Vice President Open Market Disposition -132 $355.86
2026-08-24 Corazon Sanders Former Independent Non-Executive Director Intent to Sell (Form 144) -2,075 $380.00
2026-08-24 Xiaobin Wu Former President Automatic Disposition -280 $380.00
2026-08-11 John Oyler Chairperson & CEO Automatic Disposition -240,810 $350.00–367.00
2026-08-10 Chan Lee General Counsel, Senior VP & Corporate Secretary Derivative Exercise and Sale -2,666 $159.03–360.00
2026-08-09 John Oyler Chairperson & CEO Intent to Sell (Form 144) -240,810 $348.27
2026-08-02 Aaron Rosenberg Chief Financial Officer Open Market Disposition -1,157 $312.72
2026-07-29 Chan Lee General Counsel, Senior VP & Corporate Secretary Open Market Disposition -1,044 $323.69
2026-07-21 Chan Lee General Counsel, Senior VP & Corporate Secretary Derivative Exercise and Sale -1,669 $159.03–325.00
2026-07-20 John Oyler Chairperson & CEO Automatic Disposition -75,723 $310.08–320.06
2026-07-19 John Oyler Chairperson & CEO Derivative Exercise and Sale -33,990 $119.96–318.30

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

BeiGene discussion 0 comments

Add a comment